Quantcast
Home / Practice Areas / Business and Civil Practice / Rulings give lawyers roadmap for suing drug makers for marketing fraud

Rulings give lawyers roadmap for suing drug makers for marketing fraud

In the first ruling of its kind, a federal appeals court upheld a $142 million jury verdict against drug maker Pfizer for fraudulent marketing based on statistical evidence that its marketing campaign caused doctors to prescribe epilepsy drug Neurontin for unapproved uses.